Dr Emma Burkitt-Wright graduated in medicine at the University of Liverpool in 2002. She undertook initial postgraduate training in medicine in Liverpool, gaining MRCP. After a year of paediatric experience, Dr Burkitt-Wright started her specialist training in Clinical Genetics in Manchester in 2006. During this period, she was awarded a Wellcome Trust fellowship to complete a PhD at the University of Manchester (2009-2013) and also spent time in a lab at the Spanish National Cancer Centre.

Dr Burkitt-Wright's special interests lie predominantly in disorders of the Ras-MAPK pathway, including Neurofibromatosis Type I, Noonan syndrome, and Costello and cardio-facio-cutaneous syndromes. It was the molecular basis and clinical phenotypes of these latter, rare, disorders that were the primary focus of her PhD.

She was appointed as a consultant clinical geneticist in the Manchester Centre for Genomic Medicine in 2015, working in a variety of areas of clinical genetics, including a joint clinic for patients with Ras-MAPK pathway disorders with Professor Bronwyn Kerr, clinics within the nationally commissioned highly specialised service for patients with complex neurofibromatosis type I, and also establishing a new multidisciplinary clinic for patients with Marfan syndrome and related disorders.

TBC as I am on maternity leave until February 2017

British Society for Genetic Medicine,
European Society for Human Genetics,
Membership of the Royal College of Physicians.

She also a member of the professional advisory boards of the International Costello Syndrome Support Group and the Noonan Syndrome Association.